{"id":"https://openalex.org/W4363676877","doi":"https://doi.org/10.1038/s41467-023-37785-2","title":"Hypoimmune anti-CD19 chimeric antigen receptor T cells provide lasting tumor control in fully immunocompetent allogeneic humanized mice","display_name":"Hypoimmune anti-CD19 chimeric antigen receptor T cells provide lasting tumor control in fully immunocompetent allogeneic humanized mice","publication_year":2023,"publication_date":"2023-04-10","ids":{"openalex":"https://openalex.org/W4363676877","doi":"https://doi.org/10.1038/s41467-023-37785-2","pmid":"https://pubmed.ncbi.nlm.nih.gov/37037829","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10086027"},"language":"en","primary_location":{"id":"doi:10.1038/s41467-023-37785-2","doi":"https://doi.org/10.1038/s41467-023-37785-2","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41467-023-37785-2","pdf_url":"https://www.nature.com/articles/s41467-023-37785-2.pdf","source":{"id":"https://openalex.org/S64187185","display_name":"Nature Communications","issn_l":"2041-1723","issn":["2041-1723"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Communications","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.nature.com/articles/s41467-023-37785-2.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101927716","display_name":"Xiaomeng Hu","orcid":"https://orcid.org/0000-0003-3273-4335","observed_orcids":["https://orcid.org/0000-0003-3273-4335"]},"institutions":[{"id":"https://openalex.org/I4210086146","display_name":"Sana Biotechnology (United States)","ror":"https://ror.org/00n7khb11","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086146"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaomeng Hu","raw_affiliation_strings":["Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","Sana Biotechnology Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210086146"]},{"raw_affiliation_string":"Sana Biotechnology Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210086146"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090363021","display_name":"Karl Manner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086146","display_name":"Sana Biotechnology (United States)","ror":"https://ror.org/00n7khb11","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086146"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karl Manner","raw_affiliation_strings":["Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","Sana Biotechnology Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210086146"]},{"raw_affiliation_string":"Sana Biotechnology Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210086146"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076590452","display_name":"Rowena DeJesus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086146","display_name":"Sana Biotechnology (United States)","ror":"https://ror.org/00n7khb11","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086146"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rowena DeJesus","raw_affiliation_strings":["Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","Sana Biotechnology Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210086146"]},{"raw_affiliation_string":"Sana Biotechnology Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210086146"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063958304","display_name":"Kathy A. White","orcid":"https://orcid.org/0000-0001-5329-0708","observed_orcids":["https://orcid.org/0000-0001-5329-0708"]},"institutions":[{"id":"https://openalex.org/I4210086146","display_name":"Sana Biotechnology (United States)","ror":"https://ror.org/00n7khb11","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086146"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathy White","raw_affiliation_strings":["Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","Sana Biotechnology Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210086146"]},{"raw_affiliation_string":"Sana Biotechnology Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210086146"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051219496","display_name":"Corie Gattis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086146","display_name":"Sana Biotechnology (United States)","ror":"https://ror.org/00n7khb11","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086146"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Corie Gattis","raw_affiliation_strings":["Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","Sana Biotechnology Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210086146"]},{"raw_affiliation_string":"Sana Biotechnology Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210086146"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050657538","display_name":"Priscilla Ngo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086146","display_name":"Sana Biotechnology (United States)","ror":"https://ror.org/00n7khb11","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086146"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Priscilla Ngo","raw_affiliation_strings":["Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","Sana Biotechnology Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210086146"]},{"raw_affiliation_string":"Sana Biotechnology Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210086146"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080865082","display_name":"Christopher Bandoro","orcid":"https://orcid.org/0000-0002-7615-4220","observed_orcids":["https://orcid.org/0000-0002-7615-4220"]},"institutions":[{"id":"https://openalex.org/I4210086146","display_name":"Sana Biotechnology (United States)","ror":"https://ror.org/00n7khb11","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086146"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Bandoro","raw_affiliation_strings":["Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","Sana Biotechnology Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210086146"]},{"raw_affiliation_string":"Sana Biotechnology Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210086146"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057273139","display_name":"El\u00e9onore Tham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086146","display_name":"Sana Biotechnology (United States)","ror":"https://ror.org/00n7khb11","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086146"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eleonore Tham","raw_affiliation_strings":["Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","Sana Biotechnology Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210086146"]},{"raw_affiliation_string":"Sana Biotechnology Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210086146"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074211831","display_name":"ELAINE Y.L. CHU","orcid":"https://orcid.org/0000-0001-9493-5859","observed_orcids":["https://orcid.org/0000-0001-9493-5859"]},"institutions":[{"id":"https://openalex.org/I4210086146","display_name":"Sana Biotechnology (United States)","ror":"https://ror.org/00n7khb11","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086146"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elaine Y. Chu","raw_affiliation_strings":["Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","Sana Biotechnology Inc., South San Francisco, USA"],"raw_orcid":"https://orcid.org/0000-0001-9493-5859","affiliations":[{"raw_affiliation_string":"Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210086146"]},{"raw_affiliation_string":"Sana Biotechnology Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210086146"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058234751","display_name":"Chi Young","orcid":"https://orcid.org/0000-0003-2424-0060","observed_orcids":["https://orcid.org/0000-0003-2424-0060"]},"institutions":[{"id":"https://openalex.org/I4210086146","display_name":"Sana Biotechnology (United States)","ror":"https://ror.org/00n7khb11","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086146"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chi Young","raw_affiliation_strings":["Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","Sana Biotechnology Inc., South San Francisco, USA"],"raw_orcid":"https://orcid.org/0000-0003-2424-0060","affiliations":[{"raw_affiliation_string":"Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210086146"]},{"raw_affiliation_string":"Sana Biotechnology Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210086146"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046522303","display_name":"Frank Wells","orcid":"https://orcid.org/0000-0003-0963-8943","observed_orcids":["https://orcid.org/0000-0003-0963-8943"]},"institutions":[{"id":"https://openalex.org/I4210086146","display_name":"Sana Biotechnology (United States)","ror":"https://ror.org/00n7khb11","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086146"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frank Wells","raw_affiliation_strings":["Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","Sana Biotechnology Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210086146"]},{"raw_affiliation_string":"Sana Biotechnology Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210086146"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037587552","display_name":"Ron Basco","orcid":"https://orcid.org/0000-0002-7918-4775","observed_orcids":["https://orcid.org/0000-0002-7918-4775"]},"institutions":[{"id":"https://openalex.org/I4210086146","display_name":"Sana Biotechnology (United States)","ror":"https://ror.org/00n7khb11","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086146"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronald Basco","raw_affiliation_strings":["Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","Sana Biotechnology Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210086146"]},{"raw_affiliation_string":"Sana Biotechnology Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210086146"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043439522","display_name":"Annabelle M. Friera","orcid":"https://orcid.org/0000-0003-3898-5768","observed_orcids":["https://orcid.org/0000-0003-3898-5768"]},"institutions":[{"id":"https://openalex.org/I4210086146","display_name":"Sana Biotechnology (United States)","ror":"https://ror.org/00n7khb11","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086146"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Annabelle Friera","raw_affiliation_strings":["Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","Sana Biotechnology Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210086146"]},{"raw_affiliation_string":"Sana Biotechnology Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210086146"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079103674","display_name":"Divy Kangeyan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086146","display_name":"Sana Biotechnology (United States)","ror":"https://ror.org/00n7khb11","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086146"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Divy Kangeyan","raw_affiliation_strings":["Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","Sana Biotechnology Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210086146"]},{"raw_affiliation_string":"Sana Biotechnology Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210086146"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050715885","display_name":"Pascal R. Beauchesne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086146","display_name":"Sana Biotechnology (United States)","ror":"https://ror.org/00n7khb11","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086146"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pascal Beauchesne","raw_affiliation_strings":["Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","Sana Biotechnology Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210086146"]},{"raw_affiliation_string":"Sana Biotechnology Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210086146"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026859443","display_name":"William E. Dowdle","orcid":"https://orcid.org/0000-0001-7871-8192","observed_orcids":["https://orcid.org/0000-0001-7871-8192"]},"institutions":[{"id":"https://openalex.org/I4210086146","display_name":"Sana Biotechnology (United States)","ror":"https://ror.org/00n7khb11","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086146"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William E. Dowdle","raw_affiliation_strings":["Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","Sana Biotechnology Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210086146"]},{"raw_affiliation_string":"Sana Biotechnology Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210086146"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012668274","display_name":"T. Deuse","orcid":"https://orcid.org/0000-0002-9695-4006","observed_orcids":["https://orcid.org/0000-0002-9695-4006","https://orcid.org/0000-0001-6898-0760"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tobias Deuse","raw_affiliation_strings":["Department of Surgery, Division of Cardiothoracic Surgery, Transplant and Stem Cell Immunobiology (TSI)-Lab, University of California San Francisco, San Francisco, CA, USA","Department of Surgery, Division of Cardiothoracic Surgery, Transplant and Stem Cell Immunobiology (TSI)-Lab, University of California San Francisco, San Francisco, USA"],"raw_orcid":"https://orcid.org/0000-0002-9695-4006","affiliations":[{"raw_affiliation_string":"Department of Surgery, Division of Cardiothoracic Surgery, Transplant and Stem Cell Immunobiology (TSI)-Lab, University of California San Francisco, San Francisco, CA, USA","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Department of Surgery, Division of Cardiothoracic Surgery, Transplant and Stem Cell Immunobiology (TSI)-Lab, University of California San Francisco, San Francisco, USA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017207916","display_name":"Terry J. Fry","orcid":"https://orcid.org/0000-0001-8044-5226","observed_orcids":["https://orcid.org/0000-0001-8044-5226"]},"institutions":[{"id":"https://openalex.org/I4210086146","display_name":"Sana Biotechnology (United States)","ror":"https://ror.org/00n7khb11","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086146"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Terry J. Fry","raw_affiliation_strings":["Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","Sana Biotechnology Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210086146"]},{"raw_affiliation_string":"Sana Biotechnology Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210086146"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063335678","display_name":"Aaron Edward Foster","orcid":"https://orcid.org/0009-0009-2621-7324","observed_orcids":["https://orcid.org/0009-0009-2621-7324"]},"institutions":[{"id":"https://openalex.org/I4210086146","display_name":"Sana Biotechnology (United States)","ror":"https://ror.org/00n7khb11","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086146"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron E. Foster","raw_affiliation_strings":["Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","Sana Biotechnology Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210086146"]},{"raw_affiliation_string":"Sana Biotechnology Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210086146"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040644146","display_name":"Sonja Schrepfer","orcid":"https://orcid.org/0000-0002-7696-6229","observed_orcids":["https://orcid.org/0000-0002-7696-6229"]},"institutions":[{"id":"https://openalex.org/I4210086146","display_name":"Sana Biotechnology (United States)","ror":"https://ror.org/00n7khb11","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086146"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sonja Schrepfer","raw_affiliation_strings":["Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA. Sonja.Schrepfer@sana.com","Sana Biotechnology Inc., South San Francisco, USA"],"raw_orcid":"https://orcid.org/0000-0002-7696-6229","affiliations":[{"raw_affiliation_string":"Sana Biotechnology Inc., 1 Tower Place, South San Francisco, CA, USA. Sonja.Schrepfer@sana.com","institution_ids":["https://openalex.org/I4210086146"]},{"raw_affiliation_string":"Sana Biotechnology Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210086146"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5040644146"],"corresponding_institution_ids":["https://openalex.org/I4210086146"],"apc_list":{"value":6290,"currency":"USD","value_usd":6290},"apc_paid":{"value":6290,"currency":"USD","value_usd":6290},"fwci":11.0218,"has_fulltext":true,"cited_by_count":90,"citation_normalized_percentile":{"value":0.99057723,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"14","issue":"1","first_page":"2020","last_page":"2020"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10878","display_name":"CRISPR and Genetic Engineering","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/allogeneic-car-t-cells","display_name":"allogeneic CAR T cells","score":0.9459999799728394},{"id":"https://openalex.org/keywords/anti-cd19-car","display_name":"anti-CD19 CAR","score":0.8880000114440918},{"id":"https://openalex.org/keywords/crispr-cas9-genome-editing","display_name":"CRISPR/Cas9 genome editing","score":0.8180000185966492},{"id":"https://openalex.org/keywords/t-cell-persistence","display_name":"T cell persistence","score":0.6610000133514404},{"id":"https://openalex.org/keywords/tumor-control","display_name":"tumor control","score":0.5289999842643738},{"id":"https://openalex.org/keywords/humanized-mouse-model","display_name":"humanized mice","score":0.8130000233650208},{"id":"https://openalex.org/keywords/t-cell-exhaustion","display_name":"T cell exhaustion","score":0.6029999852180481},{"id":"https://openalex.org/keywords/b-cell-acute-lymphoblastic-leukemia","display_name":"B-cell acute lymphoblastic leukemia","score":0.6240000128746033}],"concepts":[{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.9256317615509033},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.6572961807250977},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5465911626815796},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.49298974871635437},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4887392520904541},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.48658478260040283},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.48298823833465576},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4229740500450134},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.36073267459869385}],"mesh":[{"descriptor_ui":"D000076962","descriptor_name":"Receptors, Chimeric Antigen","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011948","descriptor_name":"Receptors, Antigen, T-Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018380","descriptor_name":"Hematopoietic Stem Cell Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051928","descriptor_name":"CD47 Antigen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1038/s41467-023-37785-2","doi":"https://doi.org/10.1038/s41467-023-37785-2","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41467-023-37785-2","pdf_url":"https://www.nature.com/articles/s41467-023-37785-2.pdf","source":{"id":"https://openalex.org/S64187185","display_name":"Nature Communications","issn_l":"2041-1723","issn":["2041-1723"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Communications","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10086027","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10086027","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10086027/pdf/41467_2023_Article_37785.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nat Commun","raw_type":"Text"},{"id":"pmid:37037829","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37037829","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature communications","raw_type":"Journal Article"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt0kf973ks","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/0kf973ks","pdf_url":"https://escholarship.org/content/qt0kf973ks/qt0kf973ks.pdf","source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Nature Communications, vol 14, iss 1","raw_type":"article"},{"id":"pmh:oai:RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-37785-2","doi":null,"is_oa":false,"landing_page_url":"https://www.nature.com/articles/s41467-023-37785-2","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"},{"id":"pmh:oai:doaj.org/article:11a7498d8b624c7f9293ade72a94e6d3","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/11a7498d8b624c7f9293ade72a94e6d3","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Nature Communications, Vol 14, Iss 1, Pp 1-14 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1038/s41467-023-37785-2","doi":"https://doi.org/10.1038/s41467-023-37785-2","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41467-023-37785-2","pdf_url":"https://www.nature.com/articles/s41467-023-37785-2.pdf","source":{"id":"https://openalex.org/S64187185","display_name":"Nature Communications","issn_l":"2041-1723","issn":["2041-1723"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Communications","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7469219830","display_name":"Multi-Modal Optical/ microCT system for Colorado Animal Imaging Resource","funder_award_id":"1s10od027023-01a1","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4363676877.pdf","grobid_xml":"https://content.openalex.org/works/W4363676877.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W1544331058","https://openalex.org/W1976400767","https://openalex.org/W2066186103","https://openalex.org/W2088513299","https://openalex.org/W2155353950","https://openalex.org/W2333997296","https://openalex.org/W2754671817","https://openalex.org/W2791214825","https://openalex.org/W2800777686","https://openalex.org/W2864786814","https://openalex.org/W2893585523","https://openalex.org/W2911604931","https://openalex.org/W2972117761","https://openalex.org/W2981371759","https://openalex.org/W2998345757","https://openalex.org/W3017464623","https://openalex.org/W3094048574","https://openalex.org/W3113171896","https://openalex.org/W3118995603","https://openalex.org/W3129391675","https://openalex.org/W3132274017","https://openalex.org/W3133323582","https://openalex.org/W3162374648","https://openalex.org/W3178922821","https://openalex.org/W3201226829","https://openalex.org/W4281655638","https://openalex.org/W4307234878"],"related_works":["https://openalex.org/W4362592270","https://openalex.org/W4310099653","https://openalex.org/W4282966131","https://openalex.org/W4413141320","https://openalex.org/W3214368184","https://openalex.org/W4310106425","https://openalex.org/W4417004974","https://openalex.org/W4389231162","https://openalex.org/W4417021989","https://openalex.org/W4389248440"],"abstract_inverted_index":{"Abstract":[0],"Manufacturing":[1],"autologous":[2,61],"chimeric":[3],"antigen":[4],"receptor":[5],"(CAR)":[6],"T":[7,71,88,116,124,149,153,164,174,187,196,202,224,234,248],"cell":[8,165],"therapeutics":[9,236],"is":[10],"complex,":[11],"and":[12,42,49,78,94,103,141,150,207,209,219,250],"many":[13],"patients":[14],"experience":[15],"treatment":[16],"delays":[17],"or":[18],"cannot":[19],"be":[20],"treated":[21],"at":[22],"all.":[23],"Although":[24],"current":[25],"allogeneic":[26,69,112,121,231,246],"CAR":[27,70,105,115,123,131,133,148,152,173,186,195,201,223,233,247],"products":[28],"have":[29],"the":[30,47,54,75,129,157,239],"potential":[31],"to":[32,39,44,66,120,182],"overcome":[33,238],"manufacturing":[34],"bottlenecks,":[35],"they":[36],"are":[37],"subject":[38],"immune":[40,76],"rejection":[41],"failure":[43],"persist":[45],"in":[46,176],"host,":[48],"thus":[50],"do":[51],"not":[52,161],"provide":[53],"same":[55],"level":[56],"of":[57,168,184,245],"efficacy":[58],"as":[59],"their":[60],"counterparts.":[62],"Here,":[63],"we":[64],"aimed":[65],"develop":[67],"universal":[68,230],"cells":[72,89,117,125,175,197,249],"that":[73,126,156,183,229],"evade":[74],"system":[77],"produce":[79],"a":[80],"durable":[81,252],"response.":[82],"We":[83],"generated":[84],"human":[85],"hypoimmune":[86],"(HIP)":[87],"with":[90,242],"disrupted":[91],"B2M,":[92],"CIITA,":[93],"TRAC":[95],"genes":[96],"using":[97,108],"CRISPR-Cas9":[98],"editing.":[99],"In":[100,135,189],"addition,":[101],"CD47":[102],"anti-CD19":[104,130],"were":[106,118],"expressed":[107,128],"lentiviral":[109],"transduction.":[110],"These":[111,226],"HIP":[113,151,158,172,194,222,232],"CD19":[114,122],"compared":[119],"only":[127],"(allo":[132],"T).":[134],"vitro":[136],"assays":[137],"for":[138],"cancer":[139,212],"killing":[140],"exhaustion":[142],"revealed":[143],"no":[144],"differences":[145],"between":[146],"allo":[147,185,200],"cells,":[154,203],"confirming":[155],"edits":[159],"did":[160],"negatively":[162],"affect":[163],"performance.":[166],"Clearance":[167],"CD19+":[169],"tumors":[170],"by":[171],"immunodeficient":[177],"NSG":[178],"mice":[179],"was":[180],"comparable":[181],"cells.":[188,225],"fully":[190],"immunocompetent":[191],"humanized":[192],"mice,":[193],"significantly":[198],"outperformed":[199],"showed":[204],"improved":[205],"persistence":[206,244],"expansion,":[208],"provided":[210],"lasting":[211],"clearance.":[213],"Furthermore,":[214],"CD47-targeting":[215],"safety":[216],"strategies":[217],"reliably":[218],"specifically":[220],"eliminated":[221],"findings":[227],"suggest":[228],"cell-based":[235],"might":[237],"limitations":[240],"associated":[241],"poor":[243],"exert":[251],"anti-tumor":[253],"responses.":[254]},"counts_by_year":[{"year":2026,"cited_by_count":19},{"year":2025,"cited_by_count":27},{"year":2024,"cited_by_count":36},{"year":2023,"cited_by_count":8}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2023-04-11T00:00:00"}